Alternative lengthening of telomeres as a prognostic factor in malignant fibrous histiocytomas of bone

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4959-4962

  Matsuo, Toshihiro ^a   Shimose, Shoji ^a   Kubo, Tadahiko ^a   Fujimori, J U N ^a   Yasunaga, Yuji ^a   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Bone; Human telomerase reverse transcriptase; Malignant fibrous histiocytomas; Prognosis; Telomerase

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; BONE CANCER; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TELOMERE;

ADULT; AGED; BONE NEOPLASMS; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; TELOMERASE; TELOMERE; YOUNG ADULT;

EID: 78751480783     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Blackburn EH: Telomerases. Annu Rev Biochem 61: 113-129, 1992.
2. Zakian VA: Structure and function of telomeres. Annu Rev Genet 25: 579-604, 1989.
3. de Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2882-2885, 1994.
4. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
5. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE and Reddel RR: A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11: 217-225, 2005.
6. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997.
7. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T and Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998.
8. Hiyama E and Hiyama K: Clinical utility of telomerase in cancer. Oncogene 21: 643-649, 2002.
9. Shay JW: Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. Cancer J Sci Am 4: 26-34, 1998.
10. Aogi K, Woodman A, Urquidi V, Mangham DC, Tarin D and Goodison S: Telomerase activity in soft tissue and bone sarcomas. Clin Cancer Res 6: 4776-4781, 2000.
11. Costa A, Daidone MG, Daprai L, Villa R, Cantù S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR and Zaffaroni N: Telomere maintenance mechanisms in liposarcomas: association with histologie subtypes and disease progression. Cancer Res 66: 8918-8924, 2006.
12. Matsuo T, Shay JW, Wright WE, Hiyama E, Shimose S, Kubo T, Sugita T, Yasunaga Y and Ochi M: Telomere maintenance mechanisms in soft tissue malignant fibrous histiocytomas. J Bone Joint Surg Am 91: 928-937, 2009.
13. Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB and Dome JS: Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22: 3790-3797, 2004. (Pubitemid 41095220)
14. Schneider-Stock R, Epplen JT, Walter H, Radig K, Rys J, Epplen C, Hoang-Vu C, Niezabitowski A and Roessner A: Telomeric lengths and telomerase activity in liposarcomas. Mol Carcinog 24: 144-151, 1999.
15. Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH and Ladanyi M: Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer 41: 155-162, 2004. (Pubitemid 39096741)
16. UmeharaN,OzakiT,SugiharaS,KunisadaT,MorimotoY,KawaiA,NishidaK,YoshidaA, MurakamiTandInoueH:Influenceoftelomeraseactivityonboneandsofttissuetumors. JCancerResClinOncol130:411-416,2004.(Pubitemid39044344)
17. Yan P, Benhattar J, Coindre JM and Guillou L: Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Int J Cancer 95: 851-856, 2002.
18. BielackSS,SchroedersA,FuchsN,BacciG,BauerHC,MapeliS,TomenoBandWinklerK: Malignantfibroushistiocytomaofbone:aretrospectiveEMSOSstudyof125cases. EuropeanMusculo-SkeletalOncologySociety.ActaOrthopScand70:353-360,1999. (Pubitemid29497471)
19. Dahlin DC, Unni KK and Matsuno T: Malignant (fibrous) histiocytoma of bone - fact or fancy? Cancer 39: 1508-1516, 1977.
20. Nishida J, Sim FH, Wenger DE and Unni KK: Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients. Cancer 79: 482-493, 1997. (Pubitemid 27051772)
21. Spanier SS, Enneking WF and Enriquez P: Primary malignant fibrous histiocytoma of bone. Cancer 36: 2084-2098, 1975.
22. Matsuo T, Sugita T, Shimose S, Kubo T, Yasunaga Y and Ochi M: Telomeres: Function, Shortening and Lengthening. Nova Science, New York, NY pp. 391-401, 2009.
23. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T and Matsuura Y: Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 55: 159-164, 1992.
24. GrantJD,BroccoliD,MuquitM,ManionFJ,TisdallJandOchsMF:Telometric: atoolprovidingsimplified, reproduciblemeasurementsoftelomericDNAfromconstantfieldagarosegels. Biotechniques31:1314-1318,2001.(Pubitemid33131215)
25. Unni KK: Dahlin's Bone Tumors 5th edition. Lippincott-Raven, Philadelphia, New York, pp. 217-224, 1996.
26. BryanTM,EnglezouA,Dalla-PozzaL,DunhamMAandReddelRR: Evidenceforanalternativemechanismformaintainingtelomerelengthinhumantumorsandtu mor-derivedcelllines.NatMed5:1271-1274,1997.(Pubitemid27508830)
27. Henson JD, Neumann AA, Yeager TR and Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610, 2002. (Pubitemid 34146260)
28. BacciG,PicciP,MercuriM,BertoniFandFerrariS: Neoadjuvantchemotherapyforhigh-grademalignantfibroushistiocytomaofbone. ClinOrthopRelatRes346:178-189,1998.(Pubitemid28046883)
29. Capanna R, Bertoni F, Bacchini P, Bacci G, Guerra A and Campanacci M: Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer 54: 177-187, 1984.
30. Yokoyama R, Tsuneyoshi M, Enjoji M, Shinohara N and Masuda S: Prognostic factors of malignant fibrous histiocytoma of bone. A clinical and histopathologic analysis of 34 cases. Cancer 72: 1902-1908, 1993.